Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy PepGen stock (PEPG)

Learn how to buy PepGen stock in 5 easy steps.

About 40 hours ago


-$0.46 (-2.66%)

PepGen (PEPG) is a leading biotechnology business based in the US. It opened the day at $17.70 after a previous close of $17.30. During the day the price has varied from a low of $16.22 to a high of $18.31. The latest price was $16.84 (25 minute delay). PepGen is listed on the NASDAQ and employs 65 staff. All prices are listed in US Dollars.

Our top picks for where to buy PepGen stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Best for beginners

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for cash sweep

Go to site
Advanced charts and trading tools
  • Trade stocks, ETFs and equity options without commission and $0 option contract fees
  • Earn up to 8.1% APY on your uninvested cash
  • Get a 1.5% match in cash on transferred assets up to $300 or up to 15 free fractional shares worth between $2 and $2,000

How to buy PepGen stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – PEPG. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy PepGen stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Choose a 1.5% match or up to 15 free fractional shares
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

PepGen stock price (NASDAQ: PEPG)

Use our graph to track the performance of PEPG stocks over time.

PepGen shares at a glance

Information last updated 2024-07-12.
Previous close$17.30
Change $-0.46
Change % -2.659%
Volume 102,576
Information last updated 2024-07-14.
52-week range$3.72 - $18.72
50-day moving average $15.81
200-day moving average $10.71
Wall St. target price$21.60
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.24

Is it a good time to buy PepGen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

PepGen price performance over time

Historical closes compared with the close of $16.84 from 2024-07-12

1 week (2024-07-05) 16.84
1 month (2024-06-14) -2.38%
3 months (2024-04-12) 29.54%
6 months (2024-01-12) 145.12%
1 year (2023-07-14) 108.93%
2 years (2022-07-14) 68.40%
3 years (2021-07-10) N/A
5 years (2019-07-10) N/A

PepGen financials

Gross profit TTM $0
Return on assets TTM -26.51%
Return on equity TTM -46.72%
Profit margin 0%
Book value $5.53
Market Capitalization $545.9 million

TTM: trailing 12 months

PepGen share dividends

We're not expecting PepGen to pay a dividend over the next 12 months.

PepGen share price volatility

Over the last 12 months, PepGen's shares have ranged in value from as little as $3.72 up to $18.72. A popular way to gauge a stock's volatility is its "beta".

PEPG.US volatility(beta: 1.73)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PepGen's is 1.73. This would suggest that PepGen's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

PepGen overview

PepGen Inc. , a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that is in Phase 2 clinical trial to treat Duchenne muscular dystrophy (DMD) patients. The company is also developing PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 1 clinical trial for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. PepGen Inc. was founded in 2018 and is based in Boston, Massachusetts. .

Frequently asked questions

What percentage of PepGen is owned by insiders or institutions?
Currently 0.018% of PepGen shares are held by insiders and 91.016% by institutions.
How many people work for PepGen?
Latest data suggests 65 work at PepGen.
When does the fiscal year end for PepGen?
PepGen's fiscal year ends in December.
Where is PepGen based?
PepGen's address is: 321 Harrison Avenue, Boston, MA, United States, 02118
What is PepGen's ISIN number?
PepGen's international securities identification number is: US7133171055

More guides on Finder

Ask a Question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site